Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of an AI Software for Detection of Brain Metastases on MRI: AIDED Versus UNAIDED Performance

NCT06727032 is registered in ClinicalTrials.gov with Robovision BV as lead sponsor.

NCT NCT06727032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06727032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of an AI Software for Detection of Brain Metastases on MRI: AIDED Versus UNAIDED Performance
Lead sponsor
Robovision BV
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 24, 2025
Completion date
October 31, 2025
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases